Literature DB >> 2862272

Dose-dependent absorption of disodium etidronate.

R P Gural, V S Chungi, R P Shrewsbury, L W Dittert.   

Abstract

The gastrointestinal absorption of disodium etidronate (as [14C]disodium etidronate) was investigated in the rat proximal jejunum in-situ. Studies using various initial concentrations of the drug suggested that etidronate absorption occurred by passive diffusion at initial concentrations below 0.08 M. At initial concentrations above 0.08 M, the rate of absorption was significantly greater than would be expected if passive diffusion was the only mechanism responsible for absorption. Etidronate absorption is not mediated by the carrier mechanism responsible for phosphate ion absorption.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862272     DOI: 10.1111/j.2042-7158.1985.tb03035.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women.

Authors:  W-Y Chiu; C-J Lin; W-S Yang; K-S Tsai; J-Y Reginster
Journal:  Osteoporos Int       Date:  2019-10-23       Impact factor: 4.507

3.  Risedronate gastrointestinal absorption is independent of site and rate of administration.

Authors:  D Y Mitchell; R A Eusebio; L E Dunlap; K A Pallone; J D Nesbitt; D A Russell; M E Clay; P J Bekker
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.